Particle.news

Download on the App Store

FDA Approves New Generic Mifepristone After Routine Review

Conservative backlash intensifies ahead of a Trump-ordered safety review.

Overview

  • The newly authorized version is manufactured by Evita Solutions, adding another generic option for the abortion pill.
  • Regulators framed the action as standard, noting the FDA had previously cleared a different generic formulation.
  • Mifepristone has been used for about 25 years with a second pill for most medication abortions and for some miscarriage care.
  • Students for Life Action’s Kristan Hawkins called the approval a stain on President Trump’s tenure, and Mike Pence labeled it a betrayal.
  • The Trump administration plans to reassess the drug’s safety, worrying abortion-rights advocates despite broad scientific consensus that it is safe.